Seasen Meducal Consulting Company Limited Company Information

Current Status : Live


Seasen Meducal Consulting Company Limited's Hong Kong CR Number is 3037774. Incorporation Date is 13-APR-2021. It's Winding up Mode is None. Dissolution date is None. Seasen Meducal Consulting Company Limited company is of Private company limited by shares Type.
Additional Remarks on the Seasen Meducal Consulting Company Limited company are None.

Company Data

CRN3037774
Company NameSEASEN MEDUCAL CONSULTING COMPANY LIMITED
Chinese Name香港喜悅生集團有限公司
Active StatusLive
Register of ChargesUnavailable
TypePrivate company limited by shares
See other companies with same Type - Private company limited by shares
Winding Up ModeNone
Date of Incorporation13-APR-2021
See companies with same Incorporation Date - 13-APR-2021
Date of DissolutionNone
RemarksNone
Important NoteNone
Tagsconsulting   seasen   meducal   
Find Similar Companies by these tags.

Company Name History Information :

Effective DatePrevious Name
SEASEN MEDUCAL CONSULTING COMPANY LIMITED香港喜悅生集團有限公司13-APR-2021

FAQs:

When was Seasen Meducal Consulting Company Limited incorporated?

Seasen Meducal Consulting Company Limited was incorporated on 13-APR-2021 in Hongkong.

What is the type of Seasen Meducal Consulting Company Limited?

Seasen Meducal Consulting Company Limited is classified as Private company limited by shares.

What is the current status of Seasen Meducal Consulting Company Limited Company?

The status of Seasen Meducal Consulting Company Limited is Live.

What is the CR Number of Seasen Meducal Consulting Company Limited?

The CR Number of Seasen Meducal Consulting Company Limited is 3037774.

* We are trying our best to keep all the data correct and up-to-date. It should be noted that it is not the primary source of the information on the company Seasen Meducal Consulting Company Limited. The official registry should always be referred for latest information.

Last Updated on 14-04-2021.

Check other companies added on 14-04-2021

Check out Companies Incorporated on 13-APR-2021: